Condition
Hypertonia, Muscle
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Recruiting2
Withdrawn1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06117020Phase 1Completed
Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals
NCT05527652Not ApplicableRecruiting
Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia
NCT03492060Recruiting
Longitudinal Study of Neurogenetic Disorders
NCT04188769Not ApplicableWithdrawn
Effect of Local Pressure on Muscle Activity and General Relaxation in Persons With Hypertonia Following Stroke
Showing all 4 trials